Alcon Inc. Ordinary Shares (ALC) Covered Calls

Alcon is the global leader in eye care, providing a broad portfolio of surgical and vision care products across 140 countries. The company specializes in advanced technologies for cataract, retinal, and refractive surgeries, as well as a premier range of contact lenses and ocular health solutions. Alcon focuses on innovation and surgical precision to address the increasing global demand for vision correction and preservation.

You can sell covered calls on Alcon Inc. Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ALC (prices last updated Mon 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

Alcon Inc. (ALC) is the world’s largest eye care device company, operating through two primary segments: Surgical and Vision Care. The Surgical segment offers a sophisticated array of technologies for ophthalmic procedures, including implantables (intraocular lenses or IOLs), consumables, and high-tech surgical equipment like the Centurion and Unity platforms. Alcon’s advanced technology intraocular lenses (ATIOLs), such as the PanOptix and Vivity lines, are industry leaders in correcting presbyopia and astigmatism during cataract surgery. The company also maintains a dominant position in vitreoretinal surgery and refractive laser treatments.

The Vision Care segment focuses on a wide variety of contact lenses and ocular health products. This includes daily disposable, reusable, and color-enhancing lenses under well-known brands like DAILIES, TOTAL30, and Air Optix. Alcon also produces a significant portfolio of over-the-counter and prescription products for dry eye (SYSTANE), contact lens care, and ocular allergies. By maintaining a deep focus on research and development, Alcon seeks to capture the structural growth in eye care driven by aging populations and increased digital device usage. The company’s "pure-play" focus on ophthalmology distinguishes it as a specialized leader in the broader medical technology sector.

Competitive Landscape

Alcon competes in a specialized medical device market characterized by high barriers to entry. Its primary global rival is Johnson & Johnson (Vision division), which competes directly across surgical and contact lens categories. In the vision care space, Alcon also faces competition from The Cooper Companies and Bausch + Lomb.

In the surgical equipment and IOL market, Alcon tracks against specialized players like Glaukos Corporation and STAAR Surgical. While Alcon’s broad portfolio provides an advantage through integrated hospital contracts, it must continuously innovate to fend off niche competitors. The company also monitors broader med-tech leaders such as Medtronic and Abbott Laboratories for trends in robotic surgery and global distribution.

Strategic Outlook and Innovation

Alcon’s strategic roadmap centers on accelerating product cycles and expanding its manufacturing capacity. A major pillar of innovation is the development of digital health solutions that integrate diagnostic data with surgical planning to improve patient outcomes. The company is also heavily invested in "Water Surface" lens technology, aiming to redefine comfort for contact lens wearers through materials that transition from a highly breathable core to a high-water-content surface.

Future growth is expected to come from the continued penetration of premium ATIOLs and the expansion into emerging markets where surgical volumes are increasing rapidly. Management emphasizes a disciplined capital allocation strategy that balances internal R&D with strategic acquisitions to bolster its portfolio in areas like ocular pharmaceuticals and digital diagnostics. By leveraging its heritage and focus on technical excellence, Alcon aims to maintain its position as the premier innovator in the global vision care market.

Want more examples? ALB Covered Calls | ALDX Covered Calls